110
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Restricted mean survival time in patients with chronic lymphocytic leukemia treated with chemotherapy-free regimens as first line

ORCID Icon & ORCID Icon
Page 1018 | Received 07 Sep 2020, Accepted 26 Oct 2020, Published online: 09 Nov 2020

References

  • Sheng Z, Song S, Yu M, et al. Comparison of acalabrutinib plus obinutuzumab, ibrutinib plus obinutuzumab and venetoclax plus obinutuzumab for untreated CLL: a network meta-analysis. Leuk Lymphoma. 2020. DOI:10.1080/10428194.2020.1811271
  • Messori A. The advantages of restricted mean survival time in analysing Kaplan-Meier survival curves: analysis of 55 articles published in the last 12 months. Open Science Framework; [cited 2020 Jul 6]. Available from: https://osf.io/365br/
  • Uno H, Tian L, Horiguchi M, et al. Package ≪survRM2≫, June 13, 2020; [cited 2020 Aug 1]. Available from: https://cran.r-project.org/web/packages/survRM2/survRM2.pdf.
  • Messori A, Trippoli S, Vaiani M, et al. Survival meta-analysis of individual patient data and survival meta-analysis of published (aggregate) data – is there an intermediate approach between these two opposite options? Clin Drug Invest. 2000;20(5):309–331.
  • Cumming G, Finch S. Inference by eye: confidence intervals and how to read pictures of data. Am Psychol. 2005;60:170–180.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.